Olympus Corp said on Monday it has agreed to sell its microscope unit to private equity firm Bain Capital for $3bn as the Japanese company focuses its resources on medical technology.
The unit is to be transferred to Bain on Jan. 4 next year, subject to antitrust regulatory approvals in Japan and abroad.
In a statement, Olympus said the transfer to Bain would be in its best interest to allow the business to grow with more agile and flexible decision-making based on market needs.
Bain won over global private equity firms such as Carlyle Group and KKR & Co, people with direct knowledge have said.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Private equity has been targeting Japan, the world’s third-largest economy, where conglomerates have been hiving off non-core assets.
Bain owns flash memory chip maker Kioxia Holdings Corp and is proceeding to a second bidding round for Toshiba.
In its overhaul, Olympus has invited activist investor ValueAct Capital on to its board, bought several overseas medical equipment firms and sold its digital camera business that had been a longtime money-loser.
Its shares have nearly tripled since it started to re-organise itself early in 2019.
Olympus, which began more than a century ago as a domestic maker of microscopes, spun off the unit in April for a potential sale even though it was profitable.
With assets of 165 billion yen by the end of June, the unit has forecast operating profit of 26.5 billion yen for the current financial year.
Mental health care provider membership network Alma has picked up a $130m Series D investment…
Olympus Corp said on Monday it has agreed to sell its microscope unit to private equity firm Bain…
The four largest publicly traded alternative asset managers – Apollo Global Management Inc.,…
The post Bain Capital to Buy Olympus Science-Optics Unit for $3.1bn appeared first on Private Equity Insights.